UNI-PHARMA has been recognized as a True Leader for 2024 by ICAP CRIF, an accolade that confirms the Group’s strategic growth, ongoing investment in research and innovation, and commitment to responsibly and reliably addressing the challenges of an ever-changing environment.

The distinction was based on an analysis of the financial results and EBITDA data of Greece’s 500 most profitable companies for 2023, as presented in the Business Leaders 2024 publication. UNI-PHARMA ranked among the top 200 groups in the country with the highest EBITDA earnings.

Being named a True Leader reinforces UNI-PHARMA’s position as one of the leading and robust forces in the pharmaceutical industry, showcasing its remarkable growth trajectory. The award was received on December 19, 2024, by the Group’s Vice President, Athanasios Archontikis, at a special awards ceremony held by ICAP at the Grand Hyatt Athens.